$CGON
CG Oncology, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$67.50
▼-1.24%-$0.850
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCG Oncology, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CGON down today? It is at $67.50 (-1.24%), and our scanner flagged it 92 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CGON spikes, and full due diligence on CGON — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CGON 92 times in the last 30 days. Create a free account to track $CGON, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CGON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing144Notice of proposed insider sale (144)Sep 21, 2026 · 13 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Post Leonard E Director | Sold (automatic/other) | -1K | n/a | n/a | $73K at $72.98 | Sep 15, 26 |
Post Leonard E Director | Other | 1K | n/a | 1K | $600 at $0.600 | Sep 15, 26 |
Post Leonard E Director | Sold (automatic/other) | -1K | n/a | n/a | $75K at $74.54 | Aug 14, 26 |
Post Leonard E Director | Other | 1K | n/a | 1K | $600 at $0.600 | Aug 14, 26 |
Post Leonard E Director | Sold (automatic/other) | -1K | n/a | n/a | $71K at $71.17 | Jul 15, 26 |
Post Leonard E Director | Other | 1K | n/a | 1K | $600 at $0.600 | Jul 15, 26 |
Mulay James Director | Sold (automatic/other) | -24K 0.03% of company | n/a | n/a | $1.8M at $75.16 | Jul 10, 26 |
Mulay James Director | Other | 24K 0.03% of company | n/a | 24K | $644K at $26.63 | Jul 10, 26 |
Liu Brian Guan-Chyun Director | Bought (open market) | +371K 0.4% of company | added 24% | 1.89M | $24.8M at $66.87 | Jun 25, 26 |
Post Leonard E Director | Sold (automatic/other) | -5K | n/a | n/a | $350K at $70.00 | Jun 24, 26 |
Post Leonard E Director | Other | 5K | n/a | 5K | $3K at $0.600 | Jun 24, 26 |
Post Leonard E Director | Sold (automatic/other) | -5K | n/a | n/a | $325K at $65.00 | Jun 22, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CGON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CGON last traded at $67.50, down 1.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
CG Oncology, Inc. Common stock (CGON) is next expected to report earnings on Friday, November 13, 2026, about 40 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CGON Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CGON 92 times in the last 30 days.
CGON (CG Oncology, Inc. Common stock) trades on XNAS, with a market cap of about $5.97B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CGON for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CGON discussion
Sign in to ask a question or join the discussion.